5th Edition MarketsandMarkets Real-World Data, Life Sciences Analytics and Market Access Virtual Conference (Time Zone - Eastern Standard Time (EST)

20th- 22nd October 2021

EVENT OVERVIEW

MarketsandMarkets is proud to announce the 5th Edition Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 20-22, 2021. The expanding utilization of Real World Evidence to speed up data driven choices is further developing the clinical trial experience, but healthcare in general. 

While there is extraordinary promise in utilizing Real World Data and Real World Evidence, there are some significant challenges that should be survived: potential bias of information and data sources, inadequate data sets and absence of harmonization of data between RWE data sources, access to such data, and lack of standards in evaluating the worth of Real World Evidence data. Further developing RWE is key for pharma organizations in drug development. There was big data available pre covid and now with the access data due to covid, technology enablers like AI and ML are important for big data analysis and evidence generation. Every stakeholder has faced a some impact and had to adjust. 

Tag Line
Learn how adoption of real-world evidence can be accelerated across pharmaceutical industry
Tag Line
Explore capabilities of using Artificial Intelligence & Machine Learning in taming scientific research
Tag Line
Understand the impact of innovative real-world evidence partnerships for better data

This conference will focus on above said significant challenges and hold discussion on the best practices adopted by various stakeholders with a key takeaway being better decision making. 

WHAT TO EXPECT

  • Clinical trial protocol design
  • Impact of covid on clinical trial design
  • Patients focussed drug development
  • Reimbursement schemes during the era of covid- Has it changed?
  • Partnering strategies
  • Technology enablers-Artificial Intelligence and Machine Learning for big data analytics
  • RWE in rare diseases space helping to achieving the required approvals
  • Patient identification- An important aspect of real world evidence

  • Learn about the recent trends and advancements in Real-World Evidence Generation
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical and biopharmaceutical companies who will address most critical challenges in real-world data and real-world evidence space.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading pharmaceutical companies, global regulators, and solution providers

From Pharmaceutical and Biopharmaceutical companies

Chief executives, VP’s, Directors, Global heads, Heads, Leaders, Senior Managers, Researcher, Analysts, Investigators, Scientists, Bio-Statisticians, Epidemiologists, within the following departments-

  • Real-World Evidence
  • Health Economics & Outcomes Research
  • Market Access
  • Value Access
  • Clinical Outcomes
  • Clinical Development
  • Center for Observational and Real-World Evidence  

Expression #1 of SELECT list is not in GROUP BY clause and contains nonaggregated column 'cnceventswithcrm.s.id' which is not functionally dependent on columns in GROUP BY clause; this is incompatible with sql_mode=only_full_group_by